Involvement of caspase 3 in apoptotic death of cortical neurons evoked by DNA damage

Molecular and Cellular Neurosciences

Volumn 15, Issue 4, 2000, Pages 368-379

  Keramaris, Elizabeth ^a   Stefanis, Leonidas ^b   MacLaurin, Jason ^a   Harada, Naomoto ^d   Takaku, Kazuaki ^d   Ishikawa, Tomo O ^d   Taketo, Makoto M ^d   Robertson, George S ^a,c   Nicholson, Donald W ^c   Slack, Ruth S ^a   Park, David S ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^d TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CASPASE 3; CASPASE INHIBITOR; CYTOCHROME C OXIDASE; DNA;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; DNA DAMAGE; EMBRYO; ENZYME ACTIVITY; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 17144436897     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2000.0838     Document Type: Article

References (52)

1. Anderson A. J., Su J. H., Cotman C. W. DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-jun immunoreactivity, relationship to brain area and effect of postmortem delay. J. Neurosci. 16:1996;1710-1719.
2. Baker W. J., Royer G. L., Weiss R. B. Cytarabine and neurologic toxicity. J. Clin. Oncol. 9:1991;679-693.
3. Berridge M. V., Tan A. S. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5- d -phenyltetrazolium bromide (MTT): Subcellular localization substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys. 303:1993;474-482.
4. Cecconi F., Alvarez-Bolado G., Meyer B. I., Roth K. A., Gruss P. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell. 94:1998.
5. Chen J., Jin K., Chen M., Pei W., Kawaguchi K., Greenberg D. A., Simon R. P. Early detection of DNA strand breaks in the brain after transient focal ischemia: Implications for the role of DNA damage in apoptosis and neuronal cell death. J. Neurochem. 69:1997;232-245.
6. Cotman C. W. Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease. Neurobiol. Aging. 19:1998.
7. Cregan S. P., MacLaurin J., Craig C. G., Robertson G. S., Nicholson D. W., Park D. S., Slack R. S. Bax-dependent caspase 3 activation is a key determinant in p53 induced apoptosis in neurons. J. Neurosci. 19:1999;7860-7869.
8. Deshmukh M., Vasilakos J., Deckworth T. L., Lampe P., Shivers B. D., Johnson E. M. Jr. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases. J. Cell Biol. 135:1996;1341-1354.
9. Deshmukh M., Johnson E. M. Jr. Evidence of a novel event during neuronal death: Development of competence-to-die in response to cytoplasmic cytochrome c. Neuron. 21:1998;695-705.
10. D'Mello S. R., Aglieco F., Roberts M. R., Borodezt K., Haycock J. W. A DEVD-inhibited caspase other than CPP32 is involved in the commitment of cerebellar granule neurons to apoptosis induced by K+ deprivation. J. Neurochem. 70:1998;1809-1818.
11. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50.
12. Fraser A., Evan G. A licence to kill. Cell. 85:1996;781-784.
13. Gagliardini V., Fernandez P. A., Lee R. K., Drexler H. C., Rotello R. J., Fishman M. C., Yuan J. Prevention of vertebrate neuronal death by the crmA gene. Science. 263:1994;826-828.
14. Green D. R. Apoptotic pathways: The roads to ruin. Cell. 94:1998;695-698.
15. Green D. R., Reed J. C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
16. Hakem R., Hakem A., Duncan G. S., Henderson J. T., Woo M., Soengas M. S., Elia A., de la Pompa J. L., Kagi D., Khoo W., Potter J., Yoshida R., Kaufman S. A., Lowe S. W., Penninger J. M., Mak T. W. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell. 94:1998;339-352.
17. Hawtin S. R., Dobbins A. C., Vipula J. T., Shearman M. S. B-amyloid inhibition of MTT reduction is not mimicked by inhibitors of mitochondrial respiration. Biochem. Soc. Trans. 23:1995.
18. Hengartner M. O. CED-4 is a stranger no more. Nature. 388:1997;714-715.
19. Hsiang Y. H., Hertzberg R., Hecht S., Liu L. F. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260:1985;14873-14878.
20. Hsiang Y. H., Lihou M. G., Liu L. F. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res. 49:1989;5077-5082.
21. Janicke R. U., Sprengart M. L., Wati M. R., Porter A. G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273:1998;9357-9360.
22. Johnson M. D., Xiang H., London S., Kinoshita Y., Knudson M., Mayberg M., Korsmeyer S. J., Morrison R. S. Evidence for involvement of Bax and p53, but not caspases, in radiation-induced cell death of cultured postnatal hippocampal neurons. J. Neurosci. Res. 54:1998a;721-733.
23. Johnson M. D., Kinoshita Y., Xiang H., Ghatan S., Morrison R. S. Contribution of p53-dependent caspase activation to neuronal cell death declines with neuronal maturation. J. Neurosci. 19:1999;2996-3006.
24. Kuida K., Haydar T. F., Kuan C. Y., Gu Y., Taya C., Karasuyama H., Su M. S., Rakic P., Flavell R. A. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell. 94:1998;325-337.
25. Lazebnik Y. A., Takahashi A., Moir R. D., Goldman R. D., Poirier G. G., Kaufmann S. H., Earnshaw W. C. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc. Natl. Acad. Sci. USA. 92:1995;9042-9046.
26. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
27. Liu X., Kim C., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell free extracts: Requirement for dATP and cytochrome C. Cell. 86:1996;147-157.
28. Liu Y., Peterson D. A., Kimura H., Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69:1997;581-593.
29. Mansfield S. H., Castillo M. MR of cis-platinum-induced optic neuritis. Am. J. Neuroradiat. 15:1994;1178-1180.
30. Mathews F. S. The structure, function and evolution of cytochromes. Prog. Biophys. Mol. Biol. 45:1985;1-56.
31. Morris E. J., Geller H. M. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: Evidence for cell-cycle independent toxicity. J. Cell Biol. 134:1996;757-770.
32. Morris E. J., Park D. S., Dreixler J. C., Greene L. A., Geller H. M. Signal transduction of DNA damage-induced neuronal apoptosis. Soc. Neurosci. Abstr. 23:1997.
33. Oppenheim R. W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:1991;453-501.
34. Orth K., O'Rourke K., Salvesen G. S., Dixit V. M. Molecular ordering of apoptotic mammalian ced3/ICE-like proteases. J. Biol. Chem. 271:1996;20977-20980.
35. Park D. S., Morris E. J., Greene L. A., Geller H. M. G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J. Neurosci. 17:1997;1256-1270.
36. Park D. S., Morris E. J., Stefanis L., Troy C. M., Shelanski M. L., Geller H. M., Greene L. A. Multiple pathways of neuronal death induced by DNA damaging agents, NGF deprivation, and oxidative stress. J. Neurosci. 18:1998a;830-840.
37. Park D. S., Morris E. J., Padmanabhan J., Shelanski M. L., Geller H. M., Greene L. A. Involvement of cyclin dependent kinases in the death signalling of neurons treated with DNA damaging agents. J. Cell Biol. 143:1998b;457-467.
38. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:1998;96-99.
39. Stefanis L., Park D. S., Yan C. Y. I., Farinelli S. E., Troy C. M., Shelanski M. L., Greene L. A. Induction of CPP-32-like activity in PC12 cells by withdrawal of trophic support: Dissociation from apoptosis. J. Biol. Chem. 271:1996;30663-30671.
40. Stefanis L., Burke R. E., Greene L. A. Apoptosis in neurodegenerative disorders. Curr. Opin. Neur. Curr. Opin. Neurol. 10:1997a;299-305.
41. Stefanis L., Troy C. M., Qi H., Greene L. A. Inhibitors of trypsin-like serine proteases inhibit processing of the caspase Nedd-2 and protect PC12 cells and sympathetic neurons from death evoked by withdrawal of trophic support. J. Neurochem. 69:1997b;1425-1437.
42. Stefanis L., Troy C. M., Qi H., Shelanski M. L., Greene L. A. Caspase-2 (Nedd2) processing and death of trophic factor-deprived PC12 cells and sympathetic neurons occur independently of caspase-3 (CPP32)-like activity. J. Neurosci. 18:1998;9204-9215.
43. Stefanis L., Park D. S., Friedman W., Greene L. A. Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons. J. Neurosci. 19:1999;6235-6247.
44. Troy C. M., Stefanis L., Prochiantz A., Greene L. A., Shelanski M. L. The contrasting roles of ICE family proteases and interleukin-1beta in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation. Proc. Natl. Acad. Sci. USA. 93:1996;5635-5640.
45. Troy C. M., Stefanis L., Green L. A., Shelanski M. L. Nedd2 is required for apoptosis after trophic support withdrawal, but not superoxide dismutase (SOD1) downregulation, in sympathetic neurons and PC12 cells. J. Neurosci. 17:1997;1911-1918.
46. Vogel H., Horoupian D. S. Filamentous degeneration of neurons. A possible feature of cytosine arabinoside neurotoxicity. Cancer. 71:1993;1303-1308.
47. Winkelman M. D., Hines J. D. Cerebellar degeneration caused by high-dose cytosine arabinoside: A clinicopathological study. Ann. Neurology. 14:1983;520-527.
48. Woo M., Hakem R., Soengas M. S., Duncan G. S., Shahinian A., Kagi D., Hakem A., McCurrach M., Khoo W., Kaufman S. A., Senaldi G., Howard T., Lowe S. W., Mak T. W. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Gen. Dev. 12:1998;806-819.
49. Xiang H., Kinoshita Y., Knudson C. M., Korsmeyer S. J., Schwartzkroin P. A., Morrison R. S. Bax involvement in p53-mediated neuronal cell death. J. Neurosci. 18:1998;1363-1373.
50. Yoshida H., Kong Y.-K., Yoshida R., Elia A. J., Hakem A., Hakem R., Penninger J. M., Mak T. W. Apaf 1 is required for mitochondrial pathways of apoptosis and brain development. Cell. 94:1998;739-750.
51. Yuan J., Shasham S., Ledoux S., Ellis H. M., Horvitz H. B. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleuken-1B-converting enzyme. Cell. 75:1993;641-652.
52. Zhou H., Henzel W. J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:1997;405-413.